{"version":"1.0","type":"link","title":"Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial.","author_name":"Wu JW 외","author_url":"https://prs-insight.online/author/Wu%20JW","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/155264","thumbnail_width":1200,"thumbnail_height":630}